Article Versions Notes

Korabecny J, Andrs M, Nepovimova E, Dolezal R, Babkova K, Horova A, Malinak D, Mezeiova E, Gorecki L, Sepsova V, et al. 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment. Molecules. 2015; 20(12):22084-22101. https://doi.org/10.3390/molecules201219836

Korabecny, Jan, Martin Andrs, Eugenie Nepovimova, Rafael Dolezal, Katerina Babkova, Anna Horova, David Malinak, Eva Mezeiova, Lukas Gorecki, Vendula Sepsova, and et al. 2015. "7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment" Molecules 20, no. 12: 22084-22101. https://doi.org/10.3390/molecules201219836

Korabecny, J., Andrs, M., Nepovimova, E., Dolezal, R., Babkova, K., Horova, A., Malinak, D., Mezeiova, E., Gorecki, L., Sepsova, V., Hrabinova, M., Soukup, O., Jun, D., & Kuca, K. (2015). 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment. Molecules, 20(12), 22084-22101. https://doi.org/10.3390/molecules201219836